Repurposing live attenuated trivalent MMR vaccine as cost-effective cancer immunotherapy

Overview of attention for article published in Frontiers in oncology, November 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (58th percentile)
High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

twitter: 5 X users

Citations

dimensions_citation: 2 Dimensions

Readers on

mendeley: 14 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 6 X posts from 5 X users, with an upper bound of 27,178 followers.

@JoshuaPlinge @Beck_Sall @thelucyjohnston https://t.co/avIbovmSND

28 Mar 2024

Reply Repost Favourite

@andrew79298777 @TheChiefNerd Wait. Were you trying to poke fun at the journal that published the article, but you couldn't figure out that it was "Frontiers in Oncology?" Now you're a cancer expert with more knowledge than all oncologists in the world?

10 Jun 2023

Reply Repost Favourite

@andrew79298777 @TheChiefNerd Actually, it turns out MMR vaccines can be used in cancer treatment. Maybe you just misread the paper? https://t.co/LxPbxU09rt

10 Jun 2023

Reply Repost Favourite

Repurposing live attenuated trivalent MMR vaccine as cost-effective cancer immunotherapy https://t.co/nAA8sYKOXa

02 Dec 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 2 additional X posts.